Key Details
Price
$4.32Annual EPS
-$0.69Annual ROE
-55.82%Beta
-0.45Events Calendar
Next earnings date:
Jan 07, 2025Recent quarterly earnings:
Apr 26, 2023Recent annual earnings:
Apr 26, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Screeners with GNTA included
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Genenta's CEO to present at the U.S. Senate, Washington D.C.at the meeting “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatl
MILAN and NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, is pleased to announce that the Agenzia Italiana del Farmaco (AIFA) has approved a new Phase 1 clinical trial for metastatic Renal Cell Cancer (mRCC), marking a significant expansion of the potential applications for Genenta's flagship product, Temferon™. This approval by AIFA is in line with the standards that are harmonized across European regulatory frameworks established by the European Medicines Agency (EMA).
MILAN, Italy and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (NASDAQ: GNTA) a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power of hematopoietic stem cells towards a permanent self-vaccination against cancer, will present at several upcoming scientific and investor conferences.
FAQ
- What is the primary business of Genenta Science SpA?
- What is the ticker symbol for Genenta Science SpA?
- Does Genenta Science SpA pay dividends?
- What sector is Genenta Science SpA in?
- What industry is Genenta Science SpA in?
- What country is Genenta Science SpA based in?
- When did Genenta Science SpA go public?
- Is Genenta Science SpA in the S&P 500?
- Is Genenta Science SpA in the NASDAQ 100?
- Is Genenta Science SpA in the Dow Jones?
- When was Genenta Science SpA's last earnings report?
- When does Genenta Science SpA report earnings?